RNA Delivery Function for Anticancer Therapeutics
portes grátis
RNA Delivery Function for Anticancer Therapeutics
Madkour, Loutfy H.
Taylor & Francis Ltd
10/2024
404
Mole
9781032135182
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
Chapter 01
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
RNA drugs;Delivery system;Gene carriers;Cancer therapy;Clinical translation;Nanomedicine;Dna Methylation;miRNA Expression;RNAse Iii;Checkpoint Kinase Inhibitors;miRNA Profiles;siRNA Delivery;Histone Modification;Delivery Systems;Cancer Stem Cells;Cell Cycle Progression;Chk1 Inhibition;PIWI Protein;Aptamer siRNA Chimera;miRNA Delivery;RNAi Therapeutics;Plasma miRNA-21;CHK1;miRNA Genes;miRNA Biomarkers;MiRNA Mimic;Ago Protein;DNA Hypermethylation;siRNA Conjugates
Chapter 01
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
RNA drugs;Delivery system;Gene carriers;Cancer therapy;Clinical translation;Nanomedicine;Dna Methylation;miRNA Expression;RNAse Iii;Checkpoint Kinase Inhibitors;miRNA Profiles;siRNA Delivery;Histone Modification;Delivery Systems;Cancer Stem Cells;Cell Cycle Progression;Chk1 Inhibition;PIWI Protein;Aptamer siRNA Chimera;miRNA Delivery;RNAi Therapeutics;Plasma miRNA-21;CHK1;miRNA Genes;miRNA Biomarkers;MiRNA Mimic;Ago Protein;DNA Hypermethylation;siRNA Conjugates